These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 34922323)

  • 21. Multi-center validation of an immune-related lncRNA signature for predicting survival and immune status of patients with renal cell carcinoma: an integrating machine learning-derived study.
    Liu L; Feng Y; Guo C; Weng S; Xu H; Xing Z; Zhang Y; Wang L; Han X
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12115-12129. PubMed ID: 37423959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of potential prognostic long non-coding RNA biomarkers for predicting the risk of tumor recurrence of breast cancer patients.
    Zhou M; Zhong L; Xu W; Sun Y; Zhang Z; Zhao H; Yang L; Sun J
    Sci Rep; 2016 Aug; 6():31038. PubMed ID: 27503456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence.
    Xu Z; Chen H; Sun J; Mao W; Chen S; Chen M
    Bioengineered; 2021 Dec; 12(2):11108-11125. PubMed ID: 34738881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition.
    Kalmár A; Nagy ZB; Galamb O; Csabai I; Bodor A; Wichmann B; Valcz G; Barták BK; Tulassay Z; Igaz P; Molnár B
    BMC Cancer; 2019 Nov; 19(1):1059. PubMed ID: 31694571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
    Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
    Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy.
    Mini E; Lapucci A; Perrone G; D'Aurizio R; Napoli C; Brugia M; Landini I; Tassi R; Picariello L; Simi L; Mancini I; Messerini L; Magi A; Pinzani P; Mazzei T; Tonelli F; Nobili S
    Int J Cancer; 2019 Nov; 145(9):2580-2593. PubMed ID: 30973654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating exosomal gastric cancer-associated long noncoding RNA1 as a noninvasive biomarker for predicting chemotherapy response and prognosis of advanced gastric cancer: A multi-cohort, multi-phase study.
    Song Q; Lv X; Ru Y; Dong J; Chang R; Wu D; Chen L; Wang X; Guo X
    EBioMedicine; 2022 Apr; 78():103971. PubMed ID: 35349826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A stroma-related lncRNA panel for predicting recurrence and adjuvant chemotherapy benefit in patients with early-stage colon cancer.
    Zhou R; Sun H; Zheng S; Zhang J; Zeng D; Wu J; Huang Z; Rong X; Bin J; Liao Y; Shi M; Liao W
    J Cell Mol Med; 2020 Mar; 24(5):3229-3241. PubMed ID: 31989761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a lncRNA prognostic signature-related to stem cell index and its significance in colorectal cancer.
    Wang XC; Liu Y; Long FW; Liu LR; Fan CW
    Future Oncol; 2021 Aug; 17(23):3087-3100. PubMed ID: 33910362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive Analysis of N6-Methyladenosine-Related lncRNA Signature for Predicting Prognosis and Immune Cell Infiltration in Patients with Colorectal Cancer.
    Zhao Z; Yang YB; Li XY; Li XG; Chu XD; Lin ZB; Zhang YR; Guo YG; Ding H; Pan YL; Wang L; Pan JH
    Dis Markers; 2021; 2021():8686307. PubMed ID: 34745388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel 10-gene immune-related lncRNA signature model for the prognosis of colorectal cancer.
    Ma B; Cao L; Li Y
    Math Biosci Eng; 2021 Nov; 18(6):9743-9760. PubMed ID: 34814366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer.
    Liu Z; Lu T; Li J; Wang L; Xu K; Dang Q; Liu L; Guo C; Jiao D; Sun Z; Han X
    Front Immunol; 2021; 12():702594. PubMed ID: 34394098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
    Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
    Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
    Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
    Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prognostic index based on an eleven gene signature to predict systemic recurrences in colorectal cancer.
    Kim SK; Kim SY; Kim CW; Roh SA; Ha YJ; Lee JL; Heo H; Cho DH; Lee JS; Kim YS; Kim JC
    Exp Mol Med; 2019 Oct; 51(10):1-12. PubMed ID: 31578316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic value of a seven-lncRNA signature in patients with esophageal squamous cell carcinoma: a lncRNA expression analysis.
    Weng NQ; Chi J; Wen J; Mai SJ; Zhang MY; Huang L; Liu J; Yang XZ; Xu GL; Fu JH; Wang HY
    J Transl Med; 2020 Jan; 18(1):47. PubMed ID: 32005248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of the 3-lncRNA Signature as a Prognostic Biomarker for Colorectal Cancer.
    Liu S; Cao Q; An G; Yan B; Lei L
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Prediction Model for Tumor Recurrence in Stage II-III Colorectal Cancer Patients: From a Machine Learning Model to Genomic Profiling.
    Chen PC; Yeh YM; Lin BW; Chan RH; Su PF; Liu YC; Lee CT; Chen SH; Lin PC
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of long non-coding RNA HOTTIP with progression and prognosis in colorectal cancer.
    Ren YK; Xiao Y; Wan XB; Zhao YZ; Li J; Li Y; Han GS; Chen XB; Zou QY; Wang GC; Lu CM; Xu YC; Wang YC
    Int J Clin Exp Pathol; 2015; 8(9):11458-63. PubMed ID: 26617875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of MFI2-AS1, a Novel Pivotal lncRNA for Prognosis of Stage III/IV Colorectal Cancer.
    Luo R; Song J; Zhang W; Ran L
    Dig Dis Sci; 2020 Dec; 65(12):3538-3550. PubMed ID: 31960204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.